Tag:
Prevnar 13
Latest Headlines
Latest Headlines
Pfizer revels in massive Prevnar vax job
Pfizer ( $PFE ) announced in December it had extended its advance market commitment (AMC) to the Global Alliance for Vaccine and Immunisation (GAVI) for the pneumococcal vaccine Prevnar 13. The drug
Shrinking Pfizer targeting new round of small, tailor-made buyouts and pacts
Pfizer is thinking small these days. In keeping with the deal-making theme at the J.P. Morgan conference, Pfizer ( $PFE ) CEO Ian Read carefully mapped out the pharma giant's near-term strategy, with
Pfizer's Emini targets pneumonia market with Prevnar 13
In November, Pfizer ( $PFE ) won expert backing for the use of its vaccine Prevnar 13 to protect adults over 50 from pneumococcal infections. If the FDA agrees with the panel's decision--and it usually
FDA approves Pfizer's new megablockbuster vax
The FDA has approved Pfizer's childhood vaccine Prevnar-13, which significantly expands the protection provided by Prevnar 7, a global blockbuster with $3 billion in annual sales. Analysts have
FDA panel says yes to updated Prevnar
The new Pfizer-Wyeth got good news Wednesday after an FDA panel determined that the company's updated version of childhood vaccine Prevnar--called Prevnar-13--is safe and effective. Article
FDA delays approval of Wyeth's Prevnar-13
The FDA has delayed approval of Wyeth's Prevnar-13 vaccine for three months as it takes more time to review additional data. In response to an FDA request, Wyeth submitted additional analytical
Wyeth to up vax production in pandemic
Facing a predicted wave of new pneumonia cases triggered by a second wave of swine flu, Wyeth says it's prepared to gear up production of a new and improved vaccine for infants. The vaccine, Prevnar
